InhaLac® 300
Premium fine milled DPI alpha-lactose monohydrate – Ph. Eur., USP-NF, JP, ChP
Fine milled DPI lactose further enhances aerodynamic performance, promoting efficient dispersion and reducing agglomeration in inhalation devices. Micronized DPI lactose, with an even smaller particle size, is particularly effective for modifying powder cohesion and achieving precise drug-carrier interactions, ensuring optimal deep lung deposition.
InhaLac® 300 contains 90 % of particles below 40 – 56 μm (Malvern). The reason to add this grade is to modulate the cohesiveness of the powder rather than to adjust the deposition of the API. Cohesiveness is particularly important during encapsulation.
Benefits
- High storage stability
- Highly controlled and homogenous powder characteristics
- Highest microbial quality including low endotoxins
Areas of Application
- InhaLac® 300 is a fine milled lactose suitable for use in pulmonary and nasal drug delivery.
Order your free sample!
- Dry Powder Inhalation
- Inhalation Lactose
- Fine milled Lactose DPI
- Inhalation
- Dry Powder Inhaler (DPI)
- Fines (DPI)
- Soft pallet formulations (DPI)
15kg – Carton box with aluminium laminated and PE-EVOH-PE inliner
24 months
Wasserburg am Inn, Germany
Downloads
Typical particle size distribution
Typical Product Data
- x10: 2.4 µm, x50: 16 µm, x90: 50 µm
- Span [(x90-x10)/x50]: 3.0
- % fines <5 µm: 18
- Density bulk: 0.44 g/ml
- Density tapped: 0.72 g/ml
- Hausner Ratio: 1.64
- Carr’s Index: 39 %
Specified Product Data
Particle size distribution
Sieve Method: Laser diffraction
- x10: 2.0-3.5
- x50: 14-19
- x90: 40-56
Do you have any questions or need a customised solution?